Neurociencia del consumo y dependencia de sustancias psicoactivas

4. PSICOFARMACOLOGÍA DE LA DEPENDENCIA DE LAS DIFERENTES CLASES DE DROGASGessa GL y colab. (1985) Low doses of ethanol activate dopaminergic neuronsin the ventral tegmental area. Brain Research, 348:201–203.Gessa GL y colab. (1998) Cannabinoids activate mesolimbic dopamine neurons by anaction on cannabinoid CB1 receptors. European Journal of Pharmacology, 341:39–44.Glick SD, Weaver LM, Meibach RC (1980) Lateralization of reward in rats: differencesin reinforcing thresholds. Science, 207:1093–1095.Goldberg SR, Henningfield JE (1988) Reinforcing effects of nicotine in humansand experimental animals responding under intermittent schedules of IV druginjection. Pharmacology, Biochemistry and Behavior, 30:227–234.Goldberg SR y colab. (1983) Control of behavior by intravenous nicotine injectionsin laboratory animals. Pharmacology, Biochemistry and Behavior, 19:1011–1020.Gomez TH, Roache JD, Meisch RA (2002) Orally delivered alprazolam,diazepam, and triazolam as reinforcers in rhesus monkeys. Psychopharmacology(Berlin), 161:86–94.Grahame NJ y colab. (2001) Alcohol place preference conditioning in high- andlow-alcohol preferring selected lines of mice. Pharmacology, Biochemistry andBehavior, 68:805–814.Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humansand laboratory animals: implications for problems of long-term use and abuse.Psychopharmacology (Berlín), 134:1–37.Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal andhuman drug-taking behavior. En: Mello NK, ed. Advances in substance abuse.Greenwich, CT, JAI Press:1–90.Grispoon L, Bakalar J (1986) Can drugs be used to enhance the psychotherapeuticprocess? American Journal of Psychotherapeutics, 40:393–404.Grobin AC y colab. (1998) The role of GABA(A) receptors in the acute andchronic effects of ethanol. Psychopharmacology, 139:2–19.Haefly WE (1978) Central action of benzodiazepines: general introduction.British Journal of Psychiatry, 133:231–238.Hanus L y colab. (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist ofthe cannabinoid CB1 receptor. Proceedings of the National Academy of Science ofthe United States of America, 98:3662–3665.Heishman SJ, Taylor RC, Henningfield JE (1994) Nicotine and smoking: areview of effects on human performance. Experimental and ClinicalPsychopharmacology, 2:345–395.Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamiccharacteristics of intravenous and inhaled nicotine. Journal ofPharmacology and Experimental Therapeutics, 234:1–12.Henningfield JE, Keenan RM, Clarke PBS (1996) Nicotine. En: Schuster CR,Kuhar M, eds. Pharmacological aspects of drug dependence. Berlin, Springer-Verlag:272–314.Hillard CJ, Jarrahian A (2000) The movement of N-arachidonoylethanolamine(anandamide) across cellular membranes. Chemistry and Physics of Lipids,108:123–134.113